Kenvue (KVUE) said on Monday that CEO Thibaut Mongon has left the company and stepped down from its board, with Kirk Perry succeeding him as the interim chief executive officer, effective immediately.

Kenvue Inc. (NYSE:KVUE) is one of the 10 Stocks with Huge Catalysts on the Horizon. The company names an interim CEO and ...

(Reuters) -Kenvue's has fired CEO Thibaut Mongon ... Shares of the Tylenol and Band-Aid maker rose about 3% in early trading after it named director Kirk Perry as interim CEO. Perry, who worked at ...

The basics: CEO Thibaut Mongon departs; Kirk Perry named interim leader Board launches strategic review to explore business options Perry brings 30+ years of global CPG, tech experience ...

(RTTNews) - Consumer health company Kenvue, Inc. (KVUE) announced Monday that its Board of Directors has appointed Kirk Perry as Interim Chief Executive Officer, effective immediately.

Kenvue said Monday that board member Kirk Perry will serve as interim CEO, effective immediately. Perry has served as a director since December and most recently served as CEO of Circana, a ...

Kenvue, the Johnson & Johnson spinoff that makes Tylenol and Benadryl, named director Kirk Perry as interim chief executive officer as Thibaut Mongon departs the company.

Kirk Perry ha sido director desde diciembre y recientemente se desempeñó como CEO de Circana, un proveedor de investigación de mercado. Pasó más de 20 años en Procter & Gamble en varios roles.

Kenvue announced Chief Executive Thibaut Mongon has departed the firm, and Kirk Perry, one of its directors, will serve as the interim CEO while the firm finds a permanent successor.

This week's top media moves include Teen Vogue's new style director, CEO shifts at Converse and Wolford, and more.

Kenvue named director Kirk Perry as interim CEO, while Mongon also stepped down from the board. Perry, who worked at Procter & Gamble (PG.N) for 23 years, most recently served as CEO of technology ...